BOULDER – November 02, 2026 -- Edgewise Therapeutics (Nasdaq: EWTX) granted inducement stock options on 17,250 shares and restricted stock units covering 8,626 shares to two new non-executive employees on October 30, 2026.
Options carry a $38.90 exercise price set at the grant-date close
Each option has an exercise price of $38.90 per share, equal to Edgewise's closing share price on the grant date. The awards were made under the company's 2024 Inducement Equity Incentive Plan.
Options vest over four years, with a one-year cliff
Twenty-five percent of the shares under each option vest on the first anniversary of the employee's start date. The remainder vest in 1/48th monthly installments, subject to continued service.
RSU awards vest in four equal annual tranches
One-fourth of the shares under each RSU award vest on each of the first four anniversaries of the grant date. Vesting depends on the employee's continued service.
Grants rely on the Nasdaq inducement exemption
Edgewise granted the awards as inducements material to the employees' decision to join the company, in accordance with Nasdaq Listing Rule 5635(c)(4). Each award is subject to the terms of the Inducement Plan and related agreements.